An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial.

ABSTRACT:

SUBMITTER: Alavi Darazam I 

PROVIDER: S-EPMC7586665 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature